Suppr超能文献

早期医疗补助扩大州的前列腺癌筛查

Prostate Cancer Screening in Early Medicaid Expansion States.

作者信息

Sammon Jesse D, Serrell Emily C, Karabon Patrick, Leow Jeffrey J, Abdollah Firas, Weissman Joel S, Han Paul K J, Hansen Moritz, Menon Mani, Trinh Quoc-Dien

机构信息

Maine Medical Center Research Institute and Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, Maine.

Tufts University School of Medicine, Boston, Massachusetts.

出版信息

J Urol. 2018 Jan;199(1):81-88. doi: 10.1016/j.juro.2017.07.083. Epub 2017 Jul 29.

Abstract

PURPOSE

The PPACA (Patient Protection and Affordable Care Act) of 2010 included a provision to expand Medicaid by 2014. Six states and jurisdictions elected to expand Medicaid early before 2012. This provided a natural experiment to test the association between expanded insurance coverage and preventive service utilization, including prostate cancer screening.

MATERIALS AND METHODS

Using the 2012 and 2014 BRFSS (Behavioral Risk Factor Surveillance System) surveys we identified men 40 to 64 years old who reported prostate specific antigen testing in the preceding 12 months. Sociodemographic and access to care variables were extracted. Income was stratified by the relationship to Medicaid eligibility and the federal poverty level (less than 138%, 138% to 400% and greater than 400%). The weighted prevalence of prostate specific antigen was estimated. Multivariable logistic regression models were used to evaluate factors associated with prostate specific antigen screening. Interaction analysis for Medicaid expansion was performed.

RESULTS

Among 158,103 respondents individuals in nonexpansion states had the highest incidence of prostate specific antigen screening. Nationally screening decreased between 2011 and 2013 (OR 0.87, 95% CI 0.83-0.91). In only early expansion states there was a 3% absolute increase in screening among men in the less than 138% federal poverty level, which was associated with expansion status (p = 0.04). Increased screening in early expansion states was also seen in men who were 55 to 59 years old, nonHispanic African American, Hispanic, previously married, not high school graduates and current smokers.

CONCLUSIONS

Between 2011 and 2013 there were national declines in prostate cancer screening. However, there was significant narrowing of the gap in prostate specific antigen screening between higher and low income men in Medicaid early expansion states. This may reflect improved access to preventive services among populations with historic barriers to care.

摘要

目的

2010年的《患者保护与平价医疗法案》(PPACA)包含一项到2014年扩大医疗补助计划的条款。六个州和司法管辖区选择在2012年之前提前扩大医疗补助计划。这提供了一个自然实验,以测试扩大保险覆盖范围与预防性服务利用之间的关联,包括前列腺癌筛查。

材料与方法

利用2012年和2014年的行为风险因素监测系统(BRFSS)调查,我们确定了在过去12个月内报告进行过前列腺特异性抗原检测的40至64岁男性。提取了社会人口统计学和就医相关变量。收入根据与医疗补助资格和联邦贫困水平的关系进行分层(低于138%、138%至400%以及高于400%)。估计了前列腺特异性抗原的加权患病率。使用多变量逻辑回归模型评估与前列腺特异性抗原筛查相关的因素。对医疗补助计划扩大进行了交互分析。

结果

在158,103名受访者中,未扩大医疗补助计划的州前列腺特异性抗原筛查的发生率最高。在全国范围内,2011年至2013年筛查率下降(比值比0.87,95%置信区间0.83 - 0.91)。仅在提前扩大医疗补助计划的州,联邦贫困水平低于138%的男性中筛查率绝对提高了3%,这与扩大计划状态相关(p = 0.04)。在提前扩大医疗补助计划的州,55至59岁、非西班牙裔非裔美国人、西班牙裔、曾结婚、未高中毕业以及当前吸烟者的筛查率也有所提高。

结论

2011年至2013年期间,全国前列腺癌筛查率下降。然而,在医疗补助计划提前扩大的州,高收入和低收入男性之间前列腺特异性抗原筛查的差距显著缩小。这可能反映了在过去存在就医障碍的人群中,获得预防性服务的机会有所改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验